Luis Mendonca
Porto, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Impact of empagliflozin on serum calcium and phosphate in heart failure.
Journal: Journal of cardiac failure
Published: May 20, 2026
Cystatin-C Versus Creatinine and Kidney Function in Heart Failure With Preserved Ejection Fraction: A SOGALDI-PEF Analysis.
Journal: The American journal of cardiology
Published: May 04, 2026
Polycythemia, SGLT2 inhibitors, and associated outcomes across the cardio-kidney-metabolic spectrum: a pooled analysis of randomized trials.
Journal: European journal of internal medicine
Published: March 05, 2026
Impact of dapagliflozin, spironolactone and their combination on markers of kidney function and injury: an analysis from SOGALDI-PEF.
Journal: European journal of heart failure
Published: January 26, 2026
Aldosterone antagonist combined with a SGLT2 inhibitor versus SGLT2 inhibitor monotherapy: An updated meta-analysis.
Journal: Diabetes, obesity & metabolism
Published: October 18, 2025
Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular-kidney-metabolic conditions: A pooled analysis of randomised trials.
Journal: Diabetes, obesity & metabolism
Published: October 02, 2025
Sodium-glucose co-transporter 2 inhibitors in severe estimated glomerular filtration rate deterioration across cardiovascular-kidney- metabolic conditions: A pooled analysis of randomized trials.
Journal: European journal of heart failure
Published: September 22, 2025
Albuminuria Is the Key Driver of Kidney Benefit with Aldosterone Receptor Antagonists in Type 2 Diabetes.
Journal: Journal of the American Society of Nephrology : JASN
Published: September 02, 2025
Thiazide use and MRA eligibility in type 2 diabetes with chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
Journal: Journal of nephrology
Published: August 16, 2025
Carfilzomib-Associated Thrombotic Microangiopathy in a Multiple Myeloma Patient: Complement Genetic Alterations Impact and Eculizumab Therapy.
Journal: Cureus
Published: July 31, 2025
Corrigendum to "Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia" [Kidney International Reports Volume 9, Issue 5, May 2024, Pages 1419-1428].
Journal: Kidney international reports
Published: February 24, 2025
Last Updated: 09/26/2026